American Society for Pharmacy Law

Home

A non-profit, professional association for individuals with an interest in legal issues pertaining to pharmacy, pharmaceuticals, and related products/ services. EDUCATION - PHARMACISTS/PHARMACY LAW
521250852
IČO
Normal, IL 61761 United States
Adresa
aspl.org
Web
Pharmacy_Law
Twitter (240)

Novinky

Poslední komentáře

So glad to see the Department of Treasury making strides to support small pharmacies! This is a huge win for our local healthcare providers! 💊👏
detail
It’s inspiring to witness organizations like ASPL championing diversity and inclusion in the field of pharmacy law. Together, we can make a bigger impact! 🌍✨
detail

Poslední diskuze

1. How can the American Society for Pharmacy Law further promote diversity and inclusion within the pharmacy legal profession to better reflect the communities they serve?
Odpovědí: 3, Naposledy před 1 den detail
Odpovědí: 3, Naposledy před 1 den detail
2. What are the potential implications of the recent suspension of the enforcement of the Corporate Transparency Act on small pharmacies, and how should the ASPL advocate for their interests moving forward?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
American Society for Pharmacy Law logo
American Society for Pharmacy Law
+ Sledovat
4.5
Reviews
Normal
Místo
O společnosti

- E60 -

Username Password Keep me logged in The American Society for Pharmacy Law ASPL is an organization of attorneys pharmacists pharmacistattorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy pharmacists wholesalers manufacturers state and federal government and other interested parties. ASPL is a nonprofit which encourages diversity inclusion with the Society regardless of differingbackgrounds perspectives experiences orientations origins and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose Latest News March 11 2025 CTA Suspended in Victory for Pharmacies The Department of Treasury has announced that with respect to the Corporate Transparency Act CTA not only will it not enforce any penalties or fines associated with the beneficial ownership information reporting rule under the existing regulatory deadlines but it will further not enforce any penalties or fines against U. S.

Zdravotnické podpůrné služby
23 Vacancy More Detail